Business
Voyageur Pharmaceuticals Ltd. Announces Signing LOI for Contract Manufacturing of Barium Radiographic Contrast Media with Alberta Veterinarian Laboratories Ltd.
(TheNewswire) Calgary, Alberta - TheNewswire - November 3...
About this update from Voyageur Pharmaceuticals Ltd
[{"type":"text","content":"Voyageur Pharmaceuticals Ltd. Announces Signing LOI for Contract Manufacturing of Barium Radiographic Contrast Media with Alberta Veterinarian Laboratories Ltd.\n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Calgary, Alberta -\n \n \n TheNewswire -\n \n \n November 30, 2020\n \n \n -\n \n \n Voyageur Pharmaceuticals\nLtd.\n \n \n (\n \n \n TSXV\n \n \n :\n \n \n VM\n \n \n )\n \n \n USA (\n \n \n OTC\n \n \n :\n \n \n \n VYYRF)\n \n \n \n (the \"Company\"\nor \"Voyageur\")\n \n \n announces that it has\nsigned a non-binding letter of intent with Alberta Veterinarian\nLaboratories Ltd (\"AVL\") to\n \n \n manufacture barium radiographic contrast\nmedia for Voyageur\n \n \n . Voyageur and AVL will\nnegotiate the terms of the definitive\n \n \n manufacturing\n \n \n contract and expect to have such contract in place\n \n \n in early 2021.\n \n \n AVL is an Alberta, family owned company that is led by Dr.\nMerle Olson. Dr. Olson is a member of the board of directors of\nVoyageur. AVL is in the final stages of construction of their state of\nthe art Calgary\n \n \n Good\nManufacturing Practices (GMP)\n \n \n pharmaceutical\nmanufacturing facility located in Calgary, Alberta. AVL manufactures\nboth human and veterinarian pharmaceuticals products and operates a\nHealth Canada approved medical testing laboratory. The AVL plant is\nbeing tooled for GMP manufacturing of products under the AVL, Solvet,\nRhino Clear and Voyageur brand products. AVL is building multiple\nmanufacturing lines that are planned to allocate production for\nVoyageur's radiographic barium contrast production. AVL currently has\nbarium sulfate in their inventory and initial testing and product\ndevelopment is expected to begin in late January 2021, subject to the\nexecution of a definitive\n \n \n manufacturing\n \n \n contract. Voyageur's five\nbarium contrast product lines are slated for production upon Health\nCanada approvals that are expected in the first quarter of\n2021.\n \n \n \n \n About AVL\n \n \n \n \n Alberta Veterinary Laboratories Ltd. is a\npharmaceutical manufacturing company that specializes in quality\nanimal health products and human health products. AVL creates many\ninnovative products for thousands of farmers, vets, and pet owners,\nacross Canada. AVL provides a Canadian manufacturing alternative to a\npopular anti...